Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-043062

Director sold 1,666 shares at an average $70.74 ($117,845)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2021-06-23 Sale −680 $70.20 $47,735 135,483 D
SATO VICKI L Director 2021-06-23 Sale −986 $71.11 $70,110 134,497 D
Open-market sales · 1,666 sh · avg $70.74 · $117,845
Loading xslF345X03/doc4.xml…